Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 27, Issue 4-5, Pages 263-267Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/14728222.2023.2218033
Keywords
COVID-19; senolytic drugs; global pandemic; COVID-19 therapeutics; SARS-CoV-2